POETRY: Study of Estrogen Replacement Therapy in Postmenopausal Women With Parkinson's Disease
Status:
Completed
Trial end date:
2006-03-01
Target enrollment:
Participant gender:
Summary
The primary objectives of the POETRY study are to assess the safety and tolerability of
estrogen replacement therapy (ERT) in postmenopausal women with Parkinson's disease (PD) and
to assess recruitment for a study of ERT in postmenopausal women with PD.
Phase:
Phase 2
Details
Lead Sponsor:
The Parkinson Study Group
Collaborators:
Joseph and Rosalyn Newman Foundation Wyeth is now a wholly owned subsidiary of Pfizer